Pemetrexed for Injection recalled for lack of sterility assurance
Reliance Life Sciences Private Limited is recalling Pemetrexed for Injection 500 mg/vial, manufactured for Somerset Therapeutics, LLC, for lack of sterility assurance. The recall covers four lots, 5,020 vials in total, distributed nationwide in the USA. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Set aside any vials from lots RPTH0125A, RPTH0225A, RPTH0325A (expiry Jan 31, 2028), or RPTH0725A (expiry Apr 30, 2028), and do not administer them.
- Check the NDC 70069-0835-01 on the carton and the lot number and expiry date on the vial to confirm whether a product is affected.
- The notice doesn't say how to return or replace affected vials; contact Somerset Therapeutics, LLC or Reliance Life Sciences Private Limited for instructions.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 4 products — see all of them.
Details
- Units affected
- 5,020 vials
- Illnesses reported
- None reported
- Manufactured in
- Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road, Navi Mumbai, N/A, India
- Classification
- Class II
- Recall number
- D-0672-2026
In the FDA's words
- Description
- Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01 Lack of Sterility Assurance Lot, expiry: RPTH0125A Jan 31, 2028; RPTH0225A Jan 31, 2028; RPTH0325A Jan 31, 2028; RPTH0725A Apr 30, 2028; Distribution: Nationwide in the USA Affected quantity: 5,020 vials
- Hazard
- Lack of Sterility Assurance
4 products in this recall
Somerset Therapeutics cancer drug vials recalled for lack of sterility
Reliance Life Sciences is recalling four injectable cancer drugs made for Somerset Therapeutics: Pemetrexed for Injection 100 mg and 500 mg vials, Bortezomib for Injection 3.5 mg vials, and Azacitidine for Injection 100 mg vials. The recall covers about 36,000 vials nationwide because of a lack of sterility assurance. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC.,…D-0671-2026 · 12,000 vials
- Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC.,… (this page)D-0672-2026 · 5,020 vials
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset…D-0673-2026 · 11,400 vials
- Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therap…D-0674-2026 · 8,001 vials